Commission Regulation (EC) No 1485/96 of 26 July 1996 laying down detailed rules for the application of Council Directive 92/109/EEC, as regards customer declarations of specific use relating to certain substances used in the illicit manufacture of narcotic drugs and psychotropic substances (Text with EEA relevance)
Modified by
Commission Regulation (EC) No 1533/2000of 13 July 2000amending Regulation (EC) No 1485/96 laying down detailed rules for the application of Council Directive 92/109/EEC, as regards customer declarations of specific use relating to certain substances used in the illicit manufacture of narcotic drugs and psychotropic substances(Text with EEA relevance), 32000R1533, July 14, 2000
Regulation (EC) No 273/2004 of the European Parliament and of the Councilof 11 February 2004on drug precursors(Text with EEA relevance), 32004R0273, February 18, 2004
Commission Regulation (EC) No 1485/96of 26 July 1996laying down detailed rules for the application of Council Directive 92/109/EEC, as regards customer declarations of specific use relating to certain substances used in the illicit manufacture of narcotic drugs and psychotropic substances(Text with EEA relevance)THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Community,Having regard to Council Directive 92/109/EEC of 14 December 1992 on the manufacture and the placing on the market of certain substances used in the illicit manufacture of narcotic drugs and psychotropic substancesOJ No L 370, 19. 12. 1992, p. 76., as amended by Commission Directive 93/46/EECOJ No L 159, 1. 7. 1993, p. 134., and in particular point 1 (b) of Article 2 thereof,Whereas all transactions leading to the placing on the market of scheduled substances as defined in point (a) of Article 1 (2) of Directive 92/109/EEC must be properly documented; whereas that documentation must furthermore contain a declaration from the customer which shows the specific uses of the substance;Whereas the establishment of provisions on customer declarations will help ensure that, on the occasion of each transaction, the use to be made by the customer of scheduled substances is clearly identified; whereas such identification will contribute to avoiding the diversion of scheduled substances to illicit drugs manufacture;Whereas, to take account of regular transactions between the same supplier and the customer, the possibility for the customer to provide a single declaration covering all transactions involving a category 2 substance over a period of one year maximum should be provided, under certain conditions;Whereas the provisions of this Regulation are in accordance with the opinion of the Committee set up under Article 10 of Council Regulation (EEC) No 3677/90OJ No L 357, 20. 12. 1990, p. 1., as last amended by Commission Regulation (EEC) No 3769/92OJ No L 383, 29. 12. 1992, p. 17.,HAS ADOPTED THIS REGULATION: